Abstract
Erythropoietin (EPO) is an essential growth factor for red blood cell (RBC) production, and it is mainly produced by renal EPO-producing (REP) cells in the kidneys in an anemia/hypoxia-inducible manner.[1][1],[2][2] Erythropoiesis-stimulating agents (ESAs), including recombinant human EPO (rHuEPO),
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
